The current status of reversal therapy in Japan for elderly patients with head injury treated with antithrombotic agents: A prospective multicenter observational study

[1]  R. Goel,et al.  Vitamin K antagonist reversal strategies: Systematic review and network meta‐analysis from the AABB , 2022, Transfusion.

[2]  A. Demchuk,et al.  Hematoma Expansion and Clinical Outcomes in Patients With Factor-Xa Inhibitor–Related Atraumatic Intracerebral Hemorrhage Treated Within the ANNEXA-4 Trial Versus Real-World Usual Care , 2021, Stroke.

[3]  K. Mukherjee,et al.  Eastern Association for the Surgery of Trauma Multicenter Trial: Comparison of pre-injury antithrombotic use and reversal strategies among severe traumatic brain injury patients , 2021, The journal of trauma and acute care surgery.

[4]  E. de Guise,et al.  Antithrombotic agents and traumatic brain injury in the elderly population: hemorrhage patterns and outcomes. , 2020, Journal of neurosurgery.

[5]  Aman B Patel,et al.  Evaluation of andexanet alfa and four‐factor prothrombin complex concentrate (4F‐PCC) for reversal of rivaroxaban‐ and apixaban‐associated intracranial hemorrhages , 2020, Journal of thrombosis and haemostasis : JTH.

[6]  R. Matthews,et al.  Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial , 2019, The Lancet.

[7]  S. Nomura,et al.  Risk of Deterioration of Geriatric Traumatic Brain Injury in Patients Treated with Antithrombotic Drugs. , 2019, World neurosurgery.

[8]  R. Starling,et al.  Reversal and Resumption of Antithrombotic Therapy in LVAD-Associated Intracranial Hemorrhage. , 2019, The Annals of thoracic surgery.

[9]  D. Dornbos,et al.  Reversal of Systemic Anticoagulants and Antiplatelet Therapeutics. , 2018, Neurosurgery clinics of North America.

[10]  G. Alexiou,et al.  Antithrombotic Treatment Management in Patients with Intracerebral Hemorrhage: Reversal and Restart. , 2017, Current pharmaceutical design.

[11]  C. Hawley,et al.  Traumatic brain injuries in older adults—6 years of data for one UK trauma centre: retrospective analysis of prospectively collected data , 2017, Emergency Medicine Journal.

[12]  J. Baisden,et al.  Case Report and Review of Literature of Delayed Acute Subdural Hematoma. , 2016, World neurosurgery.

[13]  J. Teitelbaum,et al.  Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage , 2016, Neurocritical Care.

[14]  A. Unterberg,et al.  Early Surgery versus Initial Conservative Treatment in Patients with Traumatic Intracerebral Hemorrhage (STITCH[Trauma]): The First Randomized Trial , 2015, Journal of neurotrauma.

[15]  K. George,et al.  Rapid warfarin reversal with factor VIIa in an elderly trauma patient with retroperitoneal hematoma. , 2009, Tennessee medicine : journal of the Tennessee Medical Association.

[16]  K. Nagata,et al.  Antithrombotic Therapy Influences Location, Enlargement, and Mortality from Intracerebral Hemorrhage , 2008, Cerebrovascular Diseases.

[17]  L. Shutter,et al.  The impact of preinjury antiplatelet and anticoagulant pharmacotherapy on outcomes in elderly patients with hemorrhagic brain injury. , 2008, Surgery.

[18]  T. Tango,et al.  A quantitative study of physiological cerebral atrophy with aging , 1987, Neuroradiology.

[19]  P. Patka,et al.  Systematic Review and Meta-Analysis: Is Pre-Injury Antiplatelet Therapy Associated with Traumatic Intracranial Hemorrhage? , 2017, Journal of neurotrauma.

[20]  Office Cabinet.  Annual Report on the Aging Society , 2010 .